Towards the identification of biomarkers of transplantation tolerance

Nature Reviews Immunology

Volumn 9, Issue 7, 2009, Pages 521-526

  Turka, Laurence A ^a,b   Lechler, Robert I ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Immune Tolerance Network   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIGEN; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 7 RECEPTOR; LIPOPOLYSACCHARIDE; MERCAPTOPURINE; RITUXIMAB; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CARDIOVASCULAR DISEASE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; DRUG MECHANISM; GENE EXPRESSION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KUPFFER CELL; LIVER GRAFT; MIXED LYMPHOCYTE REACTION; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SKIN CANCER; T CELL DEPLETION; TRANSPLANTATION TOLERANCE; UTERINE CERVIX CANCER;

ANIMALS; BIOLOGICAL MARKERS; CELL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE SUBSETS; MODELS, ANIMAL; ORGAN TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

EID: 67649847906     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2568     Document Type: Review

References (41)

1. Billingham, R. E., Brent, L. & Medawar, P. B. Actively acquired tolerance of foreign cells. Nature 172, 603-606 (1953).
2. Delmonico, F. Interview with Dr. Joseph Murray. Am. J. Transplant. 2, 803-806 (2002).
3. Hitchings, G. H. & Elion, G. B. Chemical suppresion of the immune response. Pharmacol. Rev. 15, 365-405 (1963).
4. Halloran, P. F., Bromberg, J., Kaplan, B. & Vincenti, F. Tolerance versus immunosuppression: a perspective. Am. J. Transplant. 8, 1365-1366 (2008).
5. Owen, R. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102, 400-401 (1945).
6. Ildstad, S. T. & Sachs, D. H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307, 168-170 (1984).
7. Sykes, M. Mixed chimerism and transplant tolerance. Immunity 14, 417-424 (2001).
8. Koehn, B. H. et al. Fully MHC-disparate mixed hemopoietic chimeras show specific defects in the control of chronic viral infections. J. Immunol. 179, 2616-2626 (2007).
9. Kawai, T. et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358, 353-361 (2008).
10. Cobbold, S. P., Jayasuriya, A., Nash, A., Prospero, T. D. & Waldmann, H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312, 548-551 (1984).
11. Armstrong, N. et al. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. Transplantation 66, 5-13 (1998).
12. Kirk, A. D. et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 76, 120-129 (2003).
13. Linsley, P. S. et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174, 561-569 (1991).
14. Qin, S. et al. "Infectious" transplantation tolerance. Science 259, 974-977 (1993).
15. Waldmann, H. & Cobbold, S. Regulating the immune response to transplants. a role for CD4+ regulatory cells? Immunity 14, 399-406 (2001).
16. Larsen, C. P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438 (1996).
17. Lenschow, D. J. et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257, 789-792 (1992).
18. Turka, L. A. et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl Acad. Sci. USA 89, 11102-11105 (1992).
19. Wells, A. D. et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nature Med. 5, 1303-1307 (1999).
20. Li, X. C., Strom, T. B., Turka, L. A. & Wells, A. D. T cell death and transplantation tolerance. Immunity 14, 407-416 (2001).
21. Matzinger, P. & Bevan, M. J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell. Immunol. 29, 1-5 (1977).
22. Suchin, E. J. et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166, 973-981 (2001).
23. Atkinson, A. J. et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89-95 (2001).
24. Jovanovic, V. et al. Implication of matrix metalloproteinase 7 and the noncanonical winglesstype signaling pathway in a model of kidney allograft tolerance induced by the administration of anti-donor class II antibodies. J. Immunol. 180, 1317-1325 (2008).
25. Sawitzki, B. et al. Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am. J. Transplant. 7, 1091-1102 (2007).
26. Ashton-Chess, J., Giral, M., Brouard, S. & Soulillou, J. P. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation 84, 1215-1219 (2007).
27. Crispe, I. N. et al. Cellular and molecular mechanisms of liver tolerance. Immunol. Rev. 213, 101-118 (2006).
28. Hata, K. et al. Isolation, phenotyping, and functional analysis of lymphocytes from human liver. Clin. Immunol. Immunopathol. 56, 401-419 (1990).
29. Li, Y. et al. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 86, 1837-1843 (2008).
30. Knolle, P. A. et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin. Exp. Immunol. 114, 427-433 (1998).
31. Kamada, N. et al. Mechanisms of transplantation tolerance induced by liver grafting in rats: involvement of serum factors in clonal deletion. Immunology 64, 315-317 (1988).
32. Knolle, P. A. & Limmer, A. Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. Trends Immunol. 22, 432-437 (2001).
33. Lerut, J. & Sanchez-Fueyo, A. An appraisal of tolerance in liver transplantation. Am. J. Transplant. 6, 1774-1780 (2006).
34. Brouard, S. et al. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am. J. Transplant. 5, 330-340 (2005).
35. Brouard, S. et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc. Natl Acad. Sci. USA 104, 15448-15453 (2007).
36. Hernandez-Fuentes, M. et al. Identification of immune tolerance in renal transplants. Am. J. Transplant. 8 (Suppl. 2), 292 (2008).
37. Newell, K. A. et al. A unique B cell signature associated with operational tolerance. Am. J. Transplant. 8 (Suppl.2), 316 (2008).
38. Louis, S. et al. Contrasting CD25hiCD4+T cells/ FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 81, 398-407 (2006).
39. Martinez-Llordella, M. et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J. Clin. Invest. 118, 2845-2857 (2008).
40. Hu, C. Y. et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 117, 3857-3867 (2007).
41. Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. & Tedder, T. F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118, 3420-3430 (2008).